[144] Marsh & McLennan Companies, Inc. SEC Filing

Rhea-AI Filing Summary

Marsh & McLennan Companies, Inc. (MMC) filed a Form 144 reporting a proposed sale of 21,079 common shares through Fidelity Brokerage Services (Smithfield, RI) with an aggregate market value of $4,334,896.35. The filing lists the approximate date of sale as 09/02/2025 and reports 491,624,043 shares outstanding, indicating the sale will be executed on the NYSE. The securities are reported as acquired in connection with options granted 05/01/2016, with the acquisition date shown as 09/02/2025 and payment noted as cash. The filer also disclosed a prior sale on 06/02/2025 by John Q. Doyle of 21,080 shares for gross proceeds of $4,891,614.00. The notice includes the standard representation that the selling person does not possess undisclosed material adverse information.

Positive

• Detailed disclosure of broker, share count, aggregate market value, acquisition source, and intended sale date
• Includes prior sale data (21,080 shares on 06/02/2025 for $4,891,614), improving transparency on insider dispositions

Negative

• None.

Insights

Securities Analyst

TL;DR Routine insider filing disclosing planned sale of vested option shares; no new financial performance data.

The Form 144 details a proposed sale of 21,079 common shares via a broker with an aggregate market value of $4.33 million, to be executed on 09/02/2025 on the NYSE. The securities are reported as originating from options granted in 2016, which suggests exercise/vesting events rather than market-driven dispositions. A recent, nearly identical sale of 21,080 shares on 06/02/2025 produced roughly $4.89 million in proceeds. For investors, this filing documents insider liquidity activity but does not provide company operational or earnings information.

Compliance / Corporate Governance Expert

TL;DR Filing appears procedurally complete for Rule 144 disclosure and includes required seller certification.

The notice identifies the broker, share count, aggregate value, outstanding shares, acquisition source (options granted 05/01/2016), and sale date, meeting core Form 144 disclosure elements. The filing includes the standard signature/representation regarding lack of undisclosed material adverse information and references Rule 10b5-1 considerations. There is no indication of omitted mandatory fields within the provided content, though several issuer-identifying fields in the header are blank in this extract.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	21079	4334896.35	491624043	09/02/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/02/2025	Options Granted - 05/01/2016	Issuer			21079	09/02/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
John Q. Doyle 1166 Avenue of the Americas New York NY 10036	Common	06/02/2025	21080	4891614.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does MMC's Form 144 report for 09/02/2025?

The filing reports a proposed sale of 21,079 common shares with aggregate market value of $4,334,896.35, to be sold on 09/02/2025 on the NYSE through Fidelity Brokerage Services.

How were the shares being sold by the MMC filer acquired?

The securities are reported as acquired via options granted on 05/01/2016, with the acquisition date shown as 09/02/2025 and payment indicated as cash.

Does the filing show recent insider sales for MMC?

Yes. The filing discloses a prior sale on 06/02/2025 by John Q. Doyle of 21,080 shares for gross proceeds of $4,891,614.00.

Which broker will execute the proposed MMC sale?

The broker listed is Fidelity Brokerage Services LLC, 900 Salem Street, Smithfield RI 02917.

How many MMC shares are outstanding according to the filing?

The filing reports 491,624,043 shares outstanding.